View in EDS

Hyperactive KRAS/MAPK signaling disrupts normal lymphatic vessel architecture and function.

Saved in:

Bibliographic Details
Title:	Hyperactive KRAS/MAPK signaling disrupts normal lymphatic vessel architecture and function.
Authors:	Fernandes LM; Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX, United States., Tresemer J; Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX, United States., Zhang J; McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI, United States., Rios JJ; Center for Pediatric Bone Biology and Translational Research, Scottish Rite for Children, Dallas, TX, United States.; McDermott Center for Human Growth and Development, Dallas, TX, United States., Scallan JP; Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, FL, United States., Dellinger MT; Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX, United States.; Department of Surgery, UT Southwestern Medical Center, Dallas, TX, United States.
Source:	Frontiers in cell and developmental biology [Front Cell Dev Biol] 2023 Sep 25; Vol. 11, pp. 1276333. Date of Electronic Publication: 2023 Sep 25 (Print Publication: 2023).
Publication Type:	Journal Article
Journal Info:	Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101630250 Publication Model: eCollection Cited Medium: Print ISSN: 2296-634X (Print) Linking ISSN: 2296634X NLM ISO Abbreviation: Front Cell Dev Biol Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2296-634X
DOI:	10.3389/fcell.2023.1276333